About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Mylan Arbitration Update – expert report on quantum of damages claimed filed

May 29, 2017

Click here to read more

Post navigation

Phosphagenics Newsletter May 2017

AGM Chairman and CEO Addresses

Related Posts

Phosphagenics Arbitration Award Issued

November 12, 2018

Phosphagenics Launches New Logo and Website

November 5, 2014

2016 Aug 31 Phosphagenics Poultry Feed Efficiency Study

August 31, 2016

Recent Posts

New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025
Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.